Related Experiment Videos
High speed detection of circulating tumor cells
H Ben Hsieh1, Dena Marrinucci, Kelly Bethel
1The Scripps-PARC Institute for Advanced Biomedical Science, Palo Alto Research Center, 3333 Coyote Hill Rd., Palo Alto, CA 94304, United States.
Biosensors & Bioelectronics
|February 9, 2006
Summary
A new Fiber-Optic Array Scanning Technology (FAST) cytometer rapidly detects rare circulating tumor cells in blood. This technology offers a potential point-of-care diagnostic and prognostic tool for cancer patients.
Area of Science:
- Oncology
- Biomedical Engineering
- Cell Biology
Background:
- Epithelial tumor cells are present at very low concentrations in the peripheral blood of cancer patients.
- Accurate detection of these rare cells is crucial for diagnosis and prognosis.
- Current methods for rare cell detection can be time-consuming and may require enrichment steps.
Purpose of the Study:
- To develop and evaluate a novel instrument for rapid and accurate detection of rare circulating tumor cells.
- To assess the potential of this technology as a clinical diagnostic and prognostic tool.
Main Methods:
- Development of a Fiber-Optic Array Scanning Technology (FAST) cytometer.
- Utilizing immunofluorescent labeling to identify rare cells.
- High-speed scanning of glass substrates to locate labeled cells.
- Application of the FAST cytometer to peripheral blood samples from breast cancer patients.
Main Results:
- The FAST cytometer achieves scan rates 500 times faster than conventional automated digital microscopy.
- Detection of rare circulating tumor cells without the need for an enrichment step.
- Successful detection, imaging, and re-imaging of circulating tumor cells in breast cancer patients.
- Demonstrated potential for obtaining additional cellular information through re-identification and re-staining on a fixed substrate.
Conclusions:
- The FAST cytometer provides a rapid and accurate method for detecting circulating tumor cells.
- This technology has the potential to be a clinically useful point-of-care diagnostic and prognostic tool.
- The ability to re-image and re-stain cells enhances the diagnostic information obtainable.